Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[e/Anti-e system in liver disease]

M L Resta, M A Freni, G Berlinghieri

    Bollettino Della Societa Italiana Di Biologia Sperimentale
    |October 30, 1980
    PubMed
    Summary

    Hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe) levels were analyzed in various liver disease patients. Acute viral hepatitis patients showed rapid HBeAg seroconversion, unlike those with chronic conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nutrient profiling and food prices: what is the cost of choosing healthier products?

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2019
    Same author

    Insulin-like growth factor-II is a useful marker to detect hepatocellular carcinoma?

    European journal of internal medicine·2012
    Same author

    High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder.

    Hepato-gastroenterology·2011
    Same author

    About lasting results of total carcinoma gastrectomy.

    Minerva medica·2010
    Same author

    Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.

    Minerva gastroenterologica e dietologica·2007
    Same author

    [Dietetic management of cystic fibrosis: intervention strategies].

    La Clinica terapeutica·2005

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Context:

    • Hepatitis B virus (HBV) infection encompasses a spectrum of acute and chronic liver diseases.
    • Hepatitis B e antigen (HBeAg) and its antibody (anti-HBe) are crucial serological markers for HBV infection activity and infectivity.

    Purpose:

    • To investigate the prevalence and significance of HBeAg and anti-HBe in patients with acute viral hepatitis (AVH), chronic active hepatitis (CAH), cirrhosis, and those undergoing hemodialysis.
    • To compare HBeAg/anti-HBe profiles across different HBV-related conditions and control groups.

    Summary:

    • HBeAg was highly prevalent in hemodialysis patients (94%) and those with CAH (80%), while anti-HBe was more frequent in HBsAg carriers (100%) and cirrhotics (62.5%).
    • Patients with HBsAg-positive AVH typically showed HBeAg positivity early, with seroconversion to anti-HBe by the fourth week.
    • Conversely, a high prevalence of anti-HBe was observed in CAH and cirrhosis patients, contrasting with existing literature for AVH.

    Impact:

    • These findings highlight distinct HBeAg/anti-HBe patterns in different stages and complications of Hepatitis B, aiding in disease monitoring and management.
    • The study provides valuable serological data for understanding HBV pathogenesis and progression in specific patient cohorts, including those with chronic liver disease and undergoing dialysis.

    Related Experiment Videos